Skip to main content
SpringerLink
Log in

Non-Curative Chemotherapy for Gastric Cancer

  • Chapter
Cancer: How Worthwhile is Non-Curative Treatment?

Part of the book series: Focus on Cancer ((3292))

  • 38 Accesses

Abstract

Although the incidence of gastric cancer is declining, it is still one of the leading causes of cancer deaths worldwide. The incidence of proximal tumours is increasing and these are technically more difficult to resect. Eighty per cent of tumours are too advanced at presentation to be operated upon with curative intent. In the UK in 1990, death from gastric cancer constituted 6% of all cancer deaths, accounting for some 10 000 people. This chapter examines the treatments available for the palliation of advanced gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Oye K, Shapiro MF (1984) Reporting results from chemotherapy trials. J Am Med Assoc 252:2722–2725.

    Article  CAS  Google Scholar 

  2. Glimelius B, Hoffmann K, Graf M, Pahlman L, Sjoden PO (1994) Quality of life during chemotherapy in symptomatic patients with advanced colorectal cancer. Cancer 73:556–564.

    Article  PubMed  CAS  Google Scholar 

  3. Graf M, Pahlman L, Bergstrom R, Grimelius B (1994) The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer. Br J Cancer 70:559–563.

    Article  PubMed  CAS  Google Scholar 

  4. Murad A, Santiago FF, Petroianu A (1993) Modified therapy with 5FU, doxorubicin and methotrexate in advanced gastric cancer. Cancer 72:37–41.

    Article  PubMed  CAS  Google Scholar 

  5. Glimelius B, Hoffman K, Haglund U, Nyren O, Sjoden PO (1994) Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol 5:189–190.

    PubMed  CAS  Google Scholar 

  6. Pyrhonen S, Kuitunen T, Kouri M (1992) A randomised phase III trial comparing fluorouracil, epidoxorubicin and methotrexate (FEMTX) with best supportive care in non-resectable gastric cancer. Ann Oncol S3:47.

    Google Scholar 

  7. Baker CH, Talley RW, Matter R et al. (1976) A South West Oncology Group Study: Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5FU versus methyl CCNU plus bolus weekly 5FU. Cancer 38:1–7.

    Article  PubMed  CAS  Google Scholar 

  8. Cullinan SA, Moertel CG, Wieand HF et al. (1994) Controlled evaluation of three drug combination regimens versus fluorouracil alone for the therapy of advanced gastric cancer. J Clin Oncol 12:412.

    PubMed  CAS  Google Scholar 

  9. Cullinan SA, Moertel CG, Fleming TR (1985) A comparison of three chemotherapeutic regimens in the treatment of advanced pancreatic and gastric carcinoma: fluorouracil versus fluorouracil and doxorubicin versus fluorouracil, doxorubicin and mitomycin. J Am Med Assoc 253:2061–2067.

    Article  CAS  Google Scholar 

  10. Kim NK, Park YS, Heo DS et al. (1993) A phase III randomised study of 5 fluorouracil and cisplatin versus 5 fluorouracil doxorubicin, mitomycin C versus 5 fluorouracil alone in the treatment of advanced gastric cancer. Cancer 71:3813–3818.

    Article  PubMed  CAS  Google Scholar 

  11. Levi JA, Fox RM, Tattersall MH, Woods RL, Thomson D, Gill G for the Sydney Oncology Group (1986) Analysis of a prospectively randomised comparison of doxorubicin versus 5 fluorouracil, doxorubicin and BCNU in advanced gastric cancer: implications for future studies. J Clin Oncol 4:1348–1355.

    PubMed  CAS  Google Scholar 

  12. The Gastrointestinal Tumour Study Group (1988) Triazinate and platinum efficacy in combination with 5 fluorouracil and doxorubicin. Results of a three arm randomised trial in metastatic gastric cancer. J Natl Cancer Inst 80:1011–1015.

    Article  Google Scholar 

  13. Cocconi G, Bella M, Zironi S et al. (1994) Fluorouracil, doxorubicin and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomised trial of the Italian Oncology Group for Clinical Research. J Clin Oncol 12:2687–2693.

    PubMed  CAS  Google Scholar 

  14. Wils JA, Klein HO, Wagener DJ et al. for the EORTC (1991) Sequential high dose methotrexate and fluorouracil combined with doxorubicin. A step ahead in the treatment of advanced gastric cancer trial of the European Organisation for Research and Treatment of Cancer, Gastrointestinal Tract Co-operative Group. J Clin Oncol 9:827–831.

    PubMed  CAS  Google Scholar 

  15. Kelsen D, Atiq AT, Saltz L et al. (1992) FAMTX versus etoposide, doxorubicin and cisplatin: a random assignment trial in gastric cancer. J Clin Oncol 10:541–548.

    PubMed  CAS  Google Scholar 

  16. Massuti B, Cervantes A, Anton A (1994) A phase III multicentre randomised study in advanced gastric cancer of fluorouracil + leucovorin + epirubicin + cisplatin (FLEP) versus fluorouracil + Adriamycin + methotrexate + leucovorin. FAMTX toxicity report. Ann Oncol 5 (suppl 8):76–77.

    Google Scholar 

  17. Wils JA, Wagener DJTh, Coombes RC et al. (1994) Phase III trial of fluorouracil, methotrexate and epirubicin (FEMTX versus FEMTX plus cisplatin (FEMTX-P)) in advanced gastric cancer. Ann Oncol 5(S8):79.

    Google Scholar 

  18. Findlay M, Cunningham D, Norman A et al. (1994) A phase II study in advanced gastro-oesophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5FU (ECF). Ann Oncol 5:609–616.

    PubMed  CAS  Google Scholar 

  19. Delfino C, Caccia G, Fein L et al. (1991) Cisplatin (C) epirubicin (E) and 5FU in patients with advanced gastric cancer. Eur J Cancer (ECCO 6) S2:457.

    Google Scholar 

  20. Zaniboni A, Labianca R, Martignoni G et al. (1994) ECF is an active feasibile regimen for advanced gastric cancer. A GISCAD Confirmatory Study. Ann Oncol 5(S8): 79–80.

    Google Scholar 

  21. Wilke H, Preusser P, Fink U et al. (1989) Pre-operative chemotherapy in locally advanced and non-resectable gastric cancer: a phase II study with etoposide. doxorubicin and cisplatin. J Clin Oncol 7:1318–1326.

    PubMed  CAS  Google Scholar 

  22. Plukker JTH, Mulder NH, Sleijfer DTH et al. (1991) Chemotherapy in surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5 fluorouracil. Br J Surg 78:955–958.

    Article  PubMed  CAS  Google Scholar 

  23. Harper PG, Highley M, Houston N et al. (1992) Significant palliation in advanced gastric/oesophageal adenocarcinoma with laser endoscopy and combination chemotherapy. Proc Am Soc Clin Oncol 11:472.

    Google Scholar 

  24. Barr H, Krasner N (1989) Interstitial laser photocoagulation for treating bleeding gastric cancer. Br Med J 299:659–660.

    Article  CAS  Google Scholar 

  25. Turnbull A, Kussin S, Kurtz RC, Bains M (1980) Pallitive prosthetic intubation in gastric cancer. J Surg Oncol 15:37–42.

    Article  PubMed  CAS  Google Scholar 

  26. Topazian M, Ring E, Grendell J (1992) Palliation of obstructing gastric cancer with steel mesh self-expanding endoprostheses. Gastrointest Endosc 38:58–60.

    Article  PubMed  CAS  Google Scholar 

  27. Douglass Jr HO, Lavin PT, Gondsmit A, Klaassen DG, Paul AR (1984) An Eastern Cooperative Oncology Group evaluation of combinations of methyl CCNU, mitomycin C, Adriamycin and 5 fluouroracil in advanced measurable gastric cancer (BST 2277). J Clin Oncol 2:1372–1381.

    PubMed  Google Scholar 

  28. Lawrence W Jr, McNair G (1958) The effects of surgery in patients with incurable gastric cancer. Cancer 11:28–32.

    Article  PubMed  Google Scholar 

  29. Stern JL, Denman S, Elias EG et al. (1975) The evaluation of palliative resection in advanced carcinoma of the stomach. Surgery 77:291–298.

    PubMed  CAS  Google Scholar 

  30. Ekbom GA, Gleysteen JJ (1980) Gastric malignancy: a resection for palliation. Surgery 88:476–481.

    PubMed  CAS  Google Scholar 

  31. Boddie AW Jr, McMurtrey MJ, Giacco GG, McBride CM (1983) Palliative total gastrectomy and esophagogastrectomy. Cancer 51:1195–1200.

    Article  PubMed  Google Scholar 

  32. Hallissey MT, Allum WH, Rodinsky C, Fielding JW (1988) Palliative surgery for gastric cancer. Cancer 62:440–444.

    Article  PubMed  CAS  Google Scholar 

  33. Bozzetti F, Bonfanti G, Audisio RA (1987) Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 164:151–154.

    PubMed  CAS  Google Scholar 

  34. Cazap E, Bruno M, Levy D et al. (1986) A phase II trial of 4 epidoxorubicin in advanced gastric cancer. Proc Am Soc Clin Oncol 5:356.

    Google Scholar 

  35. Comis R (1974) Integration of chemotherapy into combined modality treatment of solid tumours. Cancer Treat Rev 1:22–33.

    Google Scholar 

  36. Leichman L, Berry BT (1991) Cisplatin therapy for adenocarcinoma of the stomach. Semin Oncol 18 (suppl 3):25–33.

    PubMed  CAS  Google Scholar 

  37. Machover D, Goldschmidt E, Chollet P et al. (1986) Treatment of advanced colorectal and gastric adenocarcinomas with 5 fluorouracil and high dose folinic acid. J Clin Oncol 4:685–696.

    PubMed  CAS  Google Scholar 

  38. Moertel CG, Levin PT (1979) A phase II–III chemotherapy study in advanced gastric cancer. Cancer Treat Rep 63:1863–1872.

    PubMed  CAS  Google Scholar 

  39. Moynihan T, Hansen R, Anderson T et al. (1988) Continuous 5 fluorouracil infusion in advanced gastric carcinoma. Am J Clin Oncol 11:461–464.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Middleton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Cunningham
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medical Oncology, St Bartholomew’s Hospital, West Smithfield, London, EC1A 7BE, UK

    Maurice L. Slevin MB, ChB, MD, FRCP  & Teresa Tate FRCP, FRCR  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer-Verlag London Limited

About this chapter

Cite this chapter

Middleton, G., Cunningham, D. (1998). Non-Curative Chemotherapy for Gastric Cancer. In: Slevin, M.L., Tate, T. (eds) Cancer: How Worthwhile is Non-Curative Treatment?. Focus on Cancer. Springer, London. https://doi.org/10.1007/978-1-4471-1509-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1509-0_17

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-76083-2

  • Online ISBN: 978-1-4471-1509-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation